Bio-Rad Laboratories, Inc.
- BIO
- NYSE
- Medical devices
- Life Science Research Tools
- Clinical Diagnostics Instruments
$352.82
Today −0.25%Quote Oct 19, 2026, 08:00 PM UTC
−6.27%over the last month
Max drawdown −9.0%From 1-month high −9.0%3 months +16.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America.
Where the money comes from
Q2 2026 revenue $651.0M
- Clinical Diagnostics$399.0M61.3%
- Life Science$252.0M38.7%
Sector
Healthcare
Industry
Medical devices
Exchange
NYSE
Employees
7,450
Market value
$9.43B
Quote Oct 19
Floor
$348.68
1.2% below price
Resistance
$357.52
1.3% above price
Price vs analyst targets
14 analysts
Lowest target
$310.00Highest target
$390.00
$310.00Highest target
$390.00
- Price $352.82
- Average target $350.00
- Analysts' target range
Analysts' average target sits about 1% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free